These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32390578)

  • 1. Interleukin-4 and anxiety in adults with atopic dermatitis.
    Gray NA; Naude PJ; Esterhuizen TM; Khumalo NP; Stein DJ
    Acta Neuropsychiatr; 2020 Oct; 32(5):271-273. PubMed ID: 32390578
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologics for Atopic Dermatitis.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials.
    Blauvelt A; Rosmarin D; Bieber T; Simpson EL; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi AB; Hultsch T; Ardeleanu M
    Br J Dermatol; 2019 Jul; 181(1):196-197. PubMed ID: 30719707
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.
    Silverberg JI; Kantor R
    Dermatol Clin; 2017 Jul; 35(3):327-334. PubMed ID: 28577802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
    Charvet E; Bourrat E; Hickman G; Donadieu J; Bellanné-Chantelot C; Jachiet M; Bouaziz JD; Bagot M; Cassius C
    Clin Exp Dermatol; 2021 Oct; 46(7):1334-1335. PubMed ID: 33864281
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report.
    Ludriksone L; Elsner P; Malessa C; Settmacher U; Schliemann S
    J Dtsch Dermatol Ges; 2020 Jul; 18(7):740-742. PubMed ID: 32212242
    [No Abstract]   [Full Text] [Related]  

  • 7. Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.
    Szekely S; Vaccari D; Salmaso R; Belloni-Fortina A; Alaibac M
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):65-66. PubMed ID: 32490817
    [No Abstract]   [Full Text] [Related]  

  • 8. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.
    Yosipovitch G; Reaney M; Mastey V; Eckert L; Abbé A; Nelson L; Clark M; Williams N; Chen Z; Ardeleanu M; Akinlade B; Graham NMH; Pirozzi G; Staudinger H; Plaum S; Radin A; Gadkari A
    Br J Dermatol; 2019 Oct; 181(4):761-769. PubMed ID: 30729499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aarskog-Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?
    Calabrese G; Licata G; Buononato D; Gambardella A; De Rosa A; Argenziano G
    Clin Exp Dermatol; 2022 Feb; 47(2):452-453. PubMed ID: 34482546
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    Benzecry V; Pravettoni V; Segatto G; Marzano AV; Ferrucci S
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):261-263. PubMed ID: 32732182
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
    Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
    J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
    Br J Dermatol; 2019 Sep; 181(3):554-565. PubMed ID: 30838645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series.
    Da J; Ali K; Lu K; Lou H; Qiu Y; Shan J; Wu L
    Clin Exp Dermatol; 2022 Feb; 47(2):423-425. PubMed ID: 34482550
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults.
    Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
    J Invest Dermatol; 2019 Jun; 139(6):1388-1391. PubMed ID: 30571970
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with psoriasis and atopic dermatitis show distinct anxiety profiles.
    Takahashi H; Tsuji H; Honma M; Shibaki H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2012 Nov; 39(11):955-6. PubMed ID: 22390686
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoration of sweating disturbance in atopic dermatitis treated with dupilumab.
    Mizukawa Y; Sato Y; Ohyama M; Shiohara T
    J Dermatol Sci; 2020 Oct; 100(1):79-81. PubMed ID: 32900571
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe Adult Atopic Dermatitis: Clinical Challenges.
    Russo F; Flori ML; Gola M; Milanesi N
    Dermatitis; 2020; 31(4):e48-e49. PubMed ID: 32209869
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in atopic dermatitis.
    Dinakar C; Fineman SM; Tilles SA
    Ann Allergy Asthma Immunol; 2018 Jan; 120(1):8-9. PubMed ID: 29273133
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Darrigade AS; Legrand A; Andreu N; Jacquemin C; Boniface K; Taïeb A; Seneschal J
    Br J Dermatol; 2018 Aug; 179(2):534-536. PubMed ID: 29710431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.